Skip to main content
OpenTrials

Clinical trial condition

Pathological Conditions, Anatomical

Explore clinical trials studying Pathological Conditions, Anatomical. Study availability and eligibility vary by location and protocol.

5,878 public trials 883 recruiting studies
Refine in advanced search Browse all conditions

Pathological Conditions, Anatomical trial results

Completed

Urinary NGAL and KIM-1 After ESWL

NCT07341269

Conditions
Calculi, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Marmara University School of Medicine Urology Department Istanbul, Turkey (Türkiye)
View Trial Details
Completed

Phase IIIb, Open-label, Multi-center Study to Evaluate Safety, Tolerability and Efficacy of OAV101 Administered Intrathecally to Participants With SMA Who Discontinued Treatment With Nusinersen or Risdiplam

NCT05386680

Conditions
Atrophy, Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, +19 more
Locations
  • Boston Childrens Hospital Boston, Massachusetts, United States
  • Child Hosp Of The Kings Daughters Norfolk, Virginia, United States
  • University of Wisconsin Madison Medical School Madison, Wisconsin, United States
  • Novartis Investigative Site Parkville, Victoria, Australia
View all 13 locations
View Trial Details
Completed

Efficacy and Safety of Intrathecal OAV101 (AVXS-101) in Pediatric Patients With Type 2 Spinal Muscular Atrophy (SMA)

NCT05089656

Conditions
Atrophy, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +18 more
Locations
  • Connecticut Children's Medical Center Farmington, Connecticut, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Clinic for Special Children Strasburg, Pennsylvania, United States
  • St Jude Children's Research Hospital Memphis, Tennessee, United States
View all 42 locations
View Trial Details
Completed

Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol.

NCT05888103

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +12 more
Locations
  • Novartis Investigative Site Fuzhou, Fujian, China
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Zhongshan, Guangdong, China
View all 28 locations
View Trial Details

Related conditions